GoKawiil
Tech News
MIT Technology Review's newsletters explore how AI tools could be misused to create bioweapons, citing a 2022 study where an AI drug-discovery model generated 40,000 potentially toxic molecules in under six hours. The coverage also notes that advances in gene editing and synthetic biology have made biotech more accessible, even as safeguards remain imperfect.
TechCrunch Disrupt 2026, running October 13-15 in San Francisco, will host a fireside chat titled 'Can We Engineer Nature's Comeback?' featuring Ben Lamm, co-founder and CEO of Colossal Biosciences. The session will examine how AI and synthetic biology are being used to attempt reviving extinct species and what that means for conservation efforts.
Researchers have devised a method to operate two separate genetic codes at once without needing to re-engineer an organism's entire genome to accommodate the change. The approach was tested outside living cells, so it avoids the laborious process of altering every gene, as previous efforts required when adding new amino acids to bacterial proteins.